Description

Chemical Properties

Description

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that enhances insulin secretion and suppresses glucagon release in response to elevated glucose levels. By slowing gastric emptying and modulating energy balance pathways, it supports more stable glucose utilization and reduces fluctuations in energy intake. Its structurally extended half-life allows for sustained receptor activation, improving metabolic efficiency over time. Semaglutide is widely studied in research related to metabolic health, glucose regulation, and weight management.